ENTRY       H00845                      Disease
NAME        Familial amyloidosis
  SUBGROUP  Amyloidosis, Finnish type [DS:H02322]
DESCRIPTION The amyloidoses are a group of diseases in which proteins that are normally soluble deposit extracellularly in tissues as insoluble fibrils. The fibrils have a characteristic beta-pleated sheet configuration that renders them avid for Congo red dye. In the familial amyloidoses, a gene mutation inherited in an autosomal-dominant manner results in a single amino acid substitution that renders a plasma protein amyloidogenic. Mutations in the TTR gene are the most common cause of familial amyloidosis. The clinical features of familial amyloidosis vary depending on the underlying amyloidogenic protein and the particular amino acid affected by the mutation, ranging from peripheral and autonomic neuropathy to cardiomyopathy.
CATEGORY    Nervous system disease
BRITE       Human diseases [BR:br08402]
             Nervous system diseases
              Neurodegenerative diseases
               H00845  Familial amyloidosis
            Human diseases in ICD-11 classification [BR:br08403]
             05 Endocrine, nutritional or metabolic diseases
              Metabolic disorders
               Other metabolic disorders
                5D00  Amyloidosis
                 H00845  Familial amyloidosis
GENE        TTR [HSA:7276] [KO:K20731]
            FGA [HSA:2243] [KO:K03903]
            APOA1 [HSA:335] [KO:K08757]
            LYZ [HSA:4069] [KO:K13915]
            B2M [HSA:567] [KO:K08055]
DRUG        Tafamidis [DR:D09673]
            Tafamidis meglumine [DR:D09674]
            Patisiran sodium [DR:D10794]
            Inotersen sodium [DR:D10941]
DBLINKS     ICD-11: 5D00.2
            ICD-10: E85
            MeSH: D028226
            OMIM: 105210 105200
REFERENCE   PMID:16105087
  AUTHORS   Dember LM
  TITLE     Emerging treatment approaches for the systemic amyloidoses.
  JOURNAL   Kidney Int 68:1377-90 (2005)
            DOI:10.1111/j.1523-1755.2005.00535.x
REFERENCE   PMID:16009758
  AUTHORS   Ando Y, Nakamura M, Araki S
  TITLE     Transthyretin-related familial amyloidotic polyneuropathy.
  JOURNAL   Arch Neurol 62:1057-62 (2005)
            DOI:10.1001/archneur.62.7.1057
REFERENCE   PMID:8097946
  AUTHORS   Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R
  TITLE     Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain.
  JOURNAL   Nat Genet 3:252-5 (1993)
            DOI:10.1038/ng0393-252
REFERENCE   PMID:9931341
  AUTHORS   Yamakawa-Kobayashi K, Yanagi H, Fukayama H, Hirano C, Shimakura Y, Yamamoto N, Arinami T, Tsuchiya S, Hamaguchi H
  TITLE     Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey.
  JOURNAL   Hum Mol Genet 8:331-6 (1999)
            DOI:10.1093/hmg/8.2.331
REFERENCE   PMID:8464497
  AUTHORS   Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ, et al.
  TITLE     Human lysozyme gene mutations cause hereditary systemic amyloidosis.
  JOURNAL   Nature 362:553-7 (1993)
            DOI:10.1038/362553a0
REFERENCE   PMID:22693999
  AUTHORS   Valleix S, Gillmore JD, Bridoux F, Mangione PP, Dogan A, Nedelec B, Boimard M, Touchard G, Goujon JM, Lacombe C, Lozeron P, Adams D, Lacroix C, Maisonobe T, Plante-Bordeneuve V, Vrana JA, Theis JD, Giorgetti S, Porcari R, Ricagno S, Bolognesi M, Stoppini M, Delpech M, Pepys MB, Hawkins PN, Bellotti V
  TITLE     Hereditary systemic amyloidosis due to Asp76Asn variant beta2-microglobulin.
  JOURNAL   N Engl J Med 366:2276-83 (2012)
            DOI:10.1056/NEJMoa1201356
///
